Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorina Belotti

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cells|April 17, 2020
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with ChemotherapyAndrea Resovi, Patrizia Borsotti, Tommaso Ceruti, et al.
The American Journal of Pathology|February 11, 2014
Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanismsAlessandra Decio, Giulia Taraboletti, Veronica Patton, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapiesKatiuscia Bonezzi, Dorina Belotti, Brian J North, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulatorGurmeet Kaur, Dorina Belotti, Angelika M Burger, et al.
Molecular Cancer Therapeutics|May 18, 2005
Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapyLuigi Manenti, Elena Riccardi, Sergio Marchini, et al.
Molecular Oncology|February 4, 2025
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft modelsAlessia Anastasia, Laura Formenti, Paola Ostano, et al.
Apoptosis : an International Journal on Programmed Cell Death|July 14, 2026
KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasionDaniela Criscuolo, Rosaria Catalano, Carmela Baviello, et al.
EMBO Molecular Medicine|June 27, 2018
Soluble stroma-related biomarkers of pancreatic cancerAndrea Resovi, Maria Rosa Bani, Luca Porcu, et al.
Cancers|April 12, 2022
Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in MiceAndrea David Re Cecconi, Mara Barone, Mara Forti, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 15, 2021
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activityDenise Pinessi, Andrea Resovi, Fabio Sangalli, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cells|April 17, 2020
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with ChemotherapyAndrea Resovi, Patrizia Borsotti, Tommaso Ceruti, et al.
The American Journal of Pathology|February 11, 2014
Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanismsAlessandra Decio, Giulia Taraboletti, Veronica Patton, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapiesKatiuscia Bonezzi, Dorina Belotti, Brian J North, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulatorGurmeet Kaur, Dorina Belotti, Angelika M Burger, et al.
Molecular Cancer Therapeutics|May 18, 2005
Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapyLuigi Manenti, Elena Riccardi, Sergio Marchini, et al.
Molecular Oncology|February 4, 2025
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft modelsAlessia Anastasia, Laura Formenti, Paola Ostano, et al.
Apoptosis : an International Journal on Programmed Cell Death|July 14, 2026
KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasionDaniela Criscuolo, Rosaria Catalano, Carmela Baviello, et al.
EMBO Molecular Medicine|June 27, 2018
Soluble stroma-related biomarkers of pancreatic cancerAndrea Resovi, Maria Rosa Bani, Luca Porcu, et al.
Cancers|April 12, 2022
Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in MiceAndrea David Re Cecconi, Mara Barone, Mara Forti, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 15, 2021
Tumor vascular remodeling by thrombospondin-1 enhances drug delivery and antineoplastic activityDenise Pinessi, Andrea Resovi, Fabio Sangalli, et al.
Pageof 3